Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancerShirui Wang(Taiyuan University of Technology), Rui Li(Sichuan University)European Journal of Medicinal ChemistryJanuary 1, 202310.1016/j.ejmech.2022.115082Cited by 27SaveCiteExport RISWatch citationsRelated PapersecDNA hubs drive cooperative intermolecular oncogene expression|Nature|2021|334Enhancing transcription–replication conflict targets ecDNA-positive cancers|Nature|2024|88